Urtoxazumab
From Wikipedia, the free encyclopedia
Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escherichia coli, serotype O121. The drug is designed to bind to a toxin of this bacterium, so that it can be more easily broken down and eliminated from the body.[1][2]
[edit] References
- ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ^ López, EL; Contrini, MM; Glatstein, E; González Ayala, S; Santoro, R; Allende, D; Ezcurra, G; Teplitz, E et al (2009). "Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody Against Shiga-Like Toxin 2 in Healthy Adults and Pediatric STEC- Infected Patients.". Antimicrobial agents and chemotherapy 54 (1): 239–243. doi:10.1128/AAC.00343-09. PMC 2798559. PMID 19822704. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2798559.
|
|
|
| Fungal ("-fung-") |
|
|
| Viral ("-vi(r)-") |
|
|
| Bacterial ("-ba(c)-") |
|
Human ("-bacu-")
|
|
|
|
Mouse ("-baco-")
|
|
|
|
|
|
|
|
Humanized ("-bazu-")
|
|
|
|
| Toxin ("-tox(a)-") |
|
|
|
|
|
(what is this?) (verify)
